Endoresection of choroidal melanoma using high-frequency electric welding of biological tissues
DOI:
https://doi.org/10.31288/oftalmolzh201641114Keywords:
меланома судинної оболонки, резекція, електрозварюванняAbstract
Background: The evolution of ocular oncology over the recent decades has been characterized by the emphasis on organ saving approaches, the main method requirement being the greatest degree of radicalism of tumor resection with a minimum amount of damage to surrounding tissues.
Purpose: To assess the efficacy of endoresection for uveal melanoma, with the high-frequency electric welding used for achievement of hemostasis.
Materials and Methods: Twenty patients (21 eyes; age, 51.6 (12.43) years) with choroidal melanoma were under our observation during 2010 to 2014. Prior to any treatment, the maximum tumor thickness based on ultrasound examination (Cine Scan) was 5.4 (2.6) mm (range, 1.4 mm to 10 mm), with the mean largest basal tumor diameter of 10.8 (3.7) mm (range, 7.6 mm to 15.8 mm). Patients underwent strontium-90 brachytherapy plus transpupillary thermotherapy to devitalize the tumor. Two months to 3 years thereafter, they underwent a 20-G three-port vitrectomy during which endoresection of melanoma was performed.
Results: In 19 eyes (90%), massive hemorrhage from uveal melanoma vessles and choroidal vessels was observed during excision of tumor tissue, and was successfully resolved with high-frequency electric welding using a unipolar endovitreal probe. All patients were still alive at the end of observation period of 2 to 6 years. Two of them underwent enucleation due to progressive tumor growth and due to subacute uveitis and phthisis bulbi, respectively.
Conclusions: Endoresection is an alternative technique for the treatment of uveal melanoma, with the eye salvage rate as high as 90%. The use of high-frequency electric welding of biological tissues in endoresection of uveal melanoma allowed us to avoid choroidal and ciliary hemorrhage in all cases, thus reducing the risk of intra- and post-operative complication.
References
1.Anina IeI, Levtiukh VI. [Ophthalmological care for the population of Ukraine]. In: [Proceedings of the XII symposium on Surgical and Medication-induced Restoration of Vision]. 2001 June 29-July 1; Chernivtsi; 2001. p.8 Ukrainian
2.Brovkina AF. [Current aspects of management of choroidal melanoma: issues and questions to discuss]. Vestn Oftalmol. 2006;1:13-5 Russian
3.Brovkina AF. [Current aspects of management of uveal melanoma]. Vestn Oftalmol. 1998;3:3-5. Russian
4.Panova IE, Bukhtiiarova NV, Efimenko IN. [Transpupillary thermotherapy in organ-saving management of uveal melanoma]. Ocular Surgery & Therapy. 2004;4(3):32-6. Russian
5.Bechrakis NE, Blatsios G, Schmid E, et al. Surgical resection techniques of large uveal melanomas. Spektrum Augenheilkd. 2010;24:17-22 https://doi.org/10.1007/s00717-010-0380-3
6.G?nd?z K , Bechrakis NE. Exoresection and endoresection for uveal melanoma. Middle East Afr J Ophthalmol. 2010 Jul-Sep; 17(3): 210-6 https://doi.org/10.4103/0974-9233.65494
7.Kavanagh MC, Everman KR, Opremcak EM. Uveal melanoma with massive extrascleral extension via pars plana vitrectomy sites. Ophthal Plast Reconstr Surg. 2008 Jul-Aug;24(4):334-6 https://doi.org/10.1097/IOP.0b013e31817e91ce
8.Naumann GO, Rummelt V. Block excision of tumors of the anterior uvea. Report on 68 consecutive patients. Ophthalmology. 1996 Dec;103(12):2017-27 https://doi.org/10.1016/S0161-6420(96)30392-8
9.Shields CL, Shields JA, Cater A, et al. Plaque radiotherapy for uveal melanoma. Long term visual outcome in 1106 consecutive patients. Arch Ophthalmol. 2000 Sep;118(9):1219-28
10.Boiko EV, Shishkin MM, Yan AV. [Transsleral thermotherapy in the management of choroidal melanoma]. In: [Proceedings of the Symposium on Ocular Tumors and Tumor-like Disorders]. 2007 November 27-29; Moscow; 2007. p.31-5 Russian
11.Song WK, Yang WI, Byeon SH, et al.Clinicopathologic report of uveal melanoma with persistent exudative retinal detachment after gamma knife radiosurgery. Ophthalmologica. 2010;224(1):16-21 https://doi.org/10.1159/000233231
12.Conway RM, Poothullil AM, Daftari IK, et al. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy. Arch Ophthalmol. 2006;124:838-43 https://doi.org/10.1001/archopht.124.6.838
13.Egan K, Ryan L, Gragoudas E. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma. Arch Ophthalmol. 1998 Mar;116(3):366-70 https://doi.org/10.1001/archopht.116.3.366
14.Peyman GA, Cohen SB. Ab interno resection of uveal melanoma. Int Ophthalmol. 1986 Apr;9(1):29-36 https://doi.org/10.1007/BF00225935
15.Schmidt JC, Brieden-Azvedo S, Nietgen GW. [Therapy of radiation resistant malignant uveal melanoma with endoresection by pars plana vitrectomy in two patients]. Klin Monbl Augenheilkd. 2001 Dec;218(12):800-4 German https://doi.org/10.1055/s-2001-19691
16.Damato B, Groenewald C, McGalliard J, et al. Endoresection of choroidal melanoma. Br J Ophthalmol. 1998 Mar; 82(3):213-8 https://doi.org/10.1136/bjo.82.3.213
17.Bechrakis NE, H?cht S, Martus P, et al. [Endoresection following proton beam irradiation of large uveal melanomas]. Ophthalmologe. 2004 Apr;101(4):370-6 https://doi.org/10.1007/s00347-003-0911-2
18.Bechrakis NE, Foerster MH. Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clin. 2006 Winter;46(1):95-107 https://doi.org/10.1097/01.iio.0000195856.31324.00
19.Foster WJ, Harbour JW, Holekamp NM, et al. Pars plana vitrectomy in eyes containing a treated posterior uveal melanoma. Am J Ophthalmol. 2003 Sep;136(3):471-6 https://doi.org/10.1016/S0002-9394(03)00244-7
20.Garc?a-Arum? J, Sararols L, Martinez V, et al. Vitreoretinal surgery and endoresection in high posterior choroidal melanomas. Retina. 2001;21(5):445-52 https://doi.org/10.1097/00006982-200110000-00005
21.Brovkina AF, Saakian SV. Visual acuity after block excision of tumors of the anterior uvea with and without restoration of the round shape of the pupil. In: Proceedings of the XI Congress of the European Society of Ophthalmology. 1997 June 1-5; Budapest; p. 1602
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Н. Н. Уманец, Н. В. Пасечникова, В. А. Науменко, А. П. Малецкий, Е. П. Чеботарев, Е. С. Пухлик
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
